α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy-Reference-Cited by-同舟云学术

α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy

Published:2018-10 Issue: Volume:118 Page:40-54
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Wong Shi Quan^ORCID,Pontifex Matthew G.,Phelan Marie M.,Pidathala Chandra,Kraemer Brian C.^ORCID,Barclay Jeff W.,Berry Neil G.,O'Neill Paul M.,Burgoyne Robert D.,Morgan Alan^ORCID

Funder

Wellcome Trust

US department of Veterans Affairs

University of Liverpool

MRC Clinical Research Capabilities and Technologies Initiative

Publisher

Elsevier BV

Subject

Neurology

Reference61 articles.

1. Epigallocatechin gallate inhibits beta amyloid oligomerization in Caenorhabditis elegans and affects the daf-2/insulin-like signaling pathway;Abbas;Phytomedicine,2010

2. Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan;Alavez;Nature,2011

3. Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate;Alelyunas;Bioorg. Med. Chem. Lett.,2010

4. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040;Arthur;Nat. Commun.,2016

5. Reserpine ameliorates Abeta toxicity in the Alzheimer's disease model in Caenorhabditis elegans;Arya;Exp. Gerontol.,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising animal models for amyotrophic lateral sclerosis drug discovery: a comprehensive update;Expert Opinion on Drug Discovery;2024-08-08

2. Rebalancing the motor circuit restores movement in a Caenorhabditis elegans model for TDP-43 toxicity;Cell Reports;2024-05

3. Simple models to understand complex disease: 10 years of progress from Caenorhabditis elegans models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration;Frontiers in Neuroscience;2024-01-04

4. Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegans;International Journal of Molecular Sciences;2023-12-28

5. Caenorhabditis elegans (C. elegans) sample preparation for metabolomics and lipidomics analysis – A review;TrAC Trends in Analytical Chemistry;2023-12